KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Current Assets (2016 - 2025)

Charles River Laboratories International has reported Current Assets over the past 17 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 3.13% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 3.13%, while the annual FY2025 figure was $1.4 billion, 3.13% up from the prior year.
  • Current Assets for Q4 2025 was $1.4 billion at Charles River Laboratories International, down from $1.5 billion in the prior quarter.
  • Over five years, Current Assets peaked at $1.7 billion in Q1 2024 and troughed at $1.3 billion in Q2 2021.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: rose 17.79% in 2021 and later dropped 12.78% in 2024.
  • Year by year, Current Assets stood at $1.3 billion in 2021, then increased by 12.95% to $1.4 billion in 2022, then grew by 11.79% to $1.6 billion in 2023, then fell by 12.78% to $1.4 billion in 2024, then increased by 3.13% to $1.4 billion in 2025.
  • Business Quant data shows Current Assets for CRL at $1.4 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.